NCT01962103 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 106
- units
- Participants
- groups
- description
- nab-paclitaxel 120 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG000
- title
- Phase 1: Nab-Paclitaxel 120 mg/m^2
- description
- nab-paclitaxel 150 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG001
- title
- Phase 1: Nab-Paclitaxel 150 mg/m^2
- description
- nab-paclitaxel 180 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG002
- title
- Phase 1: Nab-Paclitaxel 180 mg/m^2
- description
- nab-paclitaxel 210 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG003
- title
- Phase 1: Nab-Paclitaxel 210 mg/m^2
- description
- nab-paclitaxel 240 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG004
- title
- Phase 1: Nab-Paclitaxel 240 mg/m^2
- description
- nab-paclitaxel 270 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG005
- title
- Phase 1: Nab-Paclitaxel 270 mg/m^2
- description
- Participants with Ewing's sarcoma: nab-paclitaxel at the RP2D (240 mg/m\^2 in participants weighing \> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.
- id
- BG006
- title
- Phase 2: Ewing's Sarcoma
- description
- Participants with neuroblastoma: nab-paclitaxel at the RP2D (240 mg/m\^2 in participants weighing \> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.
- id
- BG007
- title
- Phase 2: Neuroblastoma
- description
- Participants with rhabdomyosarcoma: nab-paclitaxel at the RP2D (240 mg/m\^2 in participants weighing \> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.
- id
- BG008
- title
- Phase 2: Rhabdomyosarcoma
- description
- Total of all reporting groups
- id
- BG009
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.32
- value
- 11.7
- group Id
- BG001
- spread
- 5.84
- value
- 12.1
- group Id
- BG002
- spread
- 4.64
- value
- 10.2
- group Id
- BG003
- spread
- 5.36
- value
- 10.2
- group Id
- BG004
- spread
- 4.63
- value
- 11.6
- group Id
- BG005
- spread
- 2.97
- value
- 12.1
- group Id
- BG006
- spread
- 4.63
- value
- 10.1
- group Id
- BG007
- spread
- 3.42
- value
- 7.1
- group Id
- BG008
- spread
- 6.42
- value
- 12.4
- group Id
- BG009
- spread
- 4.81
- value
- 10.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 9
- group Id
- BG009
- value
- 53
- title
- Female
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 9
- group Id
- BG008
- value
- 5
- group Id
- BG009
- value
- 53
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 5
- group Id
- BG009
- value
- 17
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 11
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 8
- group Id
- BG009
- value
- 65
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 24
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 11
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 12
- group Id
- BG009
- value
- 84
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 18
- title
- Not Collected or Reported
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 3
- title
- Other, Not Specified
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- title
- Black or African American
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 106
- title
- Any Prior Cancer Treatment
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 12
- group Id
- BG007
- value
- 10
- group Id
- BG008
- value
- 10
- group Id
- BG009
- value
- 75
- title
- Prior Radiation Therapy
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 10
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 78
- title
- Prior Cancer Surgeries
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 106
- title
- Prior Systemic Anticancer Therapy
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 106
- title
- Prior Systemic Anticancer Regimens
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 10
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 27
- title
- Prior Stem Cell Transplants
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 15
- title
- Other Prior Anticancer Therapies
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Participants With Any Prior Cancer Treatment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1.815
- value
- 3.69
- group Id
- BG001
- spread
- 1.832
- value
- 3.25
- group Id
- BG002
- spread
- 1.946
- value
- 3.64
- group Id
- BG003
- spread
- 2.461
- value
- 3.64
- group Id
- BG004
- spread
- 1.309
- value
- 3.00
- group Id
- BG005
- spread
- 0.816
- value
- 3.00
- group Id
- BG006
- spread
- 0.519
- value
- 2.50
- group Id
- BG007
- spread
- 0.663
- value
- 2.14
- group Id
- BG008
- spread
- 0.579
- value
- 2.21
- group Id
- BG009
- spread
- 1.552
- value
- 2.99
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Number of Prior Systemic Anticancer Regimens Received
- unit Of Measure
- systemic anticancer regimens
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 106
- units
- Participants
- groups
- description
- nab-paclitaxel 120 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG000
- title
- Phase 1: Nab-Paclitaxel 120 mg/m^2
- description
- nab-paclitaxel 150 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG001
- title
- Phase 1: Nab-Paclitaxel 150 mg/m^2
- description
- nab-paclitaxel 180 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG002
- title
- Phase 1: Nab-Paclitaxel 180 mg/m^2
- description
- nab-paclitaxel 210 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG003
- title
- Phase 1: Nab-Paclitaxel 210 mg/m^2
- description
- nab-paclitaxel 240 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG004
- title
- Phase 1: Nab-Paclitaxel 240 mg/m^2
- description
- nab-paclitaxel 270 mg/m\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.
- id
- BG005
- title
- Phase 1: Nab-Paclitaxel 270 mg/m^2
- description
- Participants with Ewing's sarcoma: nab-paclitaxel at the RP2D (240 mg/m\^2 in participants weighing \> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.
- id
- BG006
- title
- Phase 2: Ewing's Sarcoma
- description
- Participants with neuroblastoma: nab-paclitaxel at the RP2D (240 mg/m\^2 in participants weighing \> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.
- id
- BG007
- title
- Phase 2: Neuroblastoma
- description
- Participants with rhabdomyosarcoma: nab-paclitaxel at the RP2D (240 mg/m\^2 in participants weighing \> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.
- id
- BG008
- title
- Phase 2: Rhabdomyosarcoma
- description
- Total of all reporting groups
- id
- BG009
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.32
- value
- 11.7
- group Id
- BG001
- spread
- 5.84
- value
- 12.1
- group Id
- BG002
- spread
- 4.64
- value
- 10.2
- group Id
- BG003
- spread
- 5.36
- value
- 10.2
- group Id
- BG004
- spread
- 4.63
- value
- 11.6
- group Id
- BG005
- spread
- 2.97
- value
- 12.1
- group Id
- BG006
- spread
- 4.63
- value
- 10.1
- group Id
- BG007
- spread
- 3.42
- value
- 7.1
- group Id
- BG008
- spread
- 6.42
- value
- 12.4
- group Id
- BG009
- spread
- 4.81
- value
- 10.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 9
- group Id
- BG009
- value
- 53
- title
- Female
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 8
- group Id
- BG007
- value
- 9
- group Id
- BG008
- value
- 5
- group Id
- BG009
- value
- 53
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 5
- group Id
- BG009
- value
- 17
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 11
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 8
- group Id
- BG009
- value
- 65
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 24
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 11
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 12
- group Id
- BG009
- value
- 84
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 18
- title
- Not Collected or Reported
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 3
- title
- Other, Not Specified
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- title
- Black or African American
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 106
- title
- Any Prior Cancer Treatment
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 12
- group Id
- BG007
- value
- 10
- group Id
- BG008
- value
- 10
- group Id
- BG009
- value
- 75
- title
- Prior Radiation Therapy
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 10
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 78
- title
- Prior Cancer Surgeries
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 106
- title
- Prior Systemic Anticancer Therapy
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 14
- group Id
- BG008
- value
- 14
- group Id
- BG009
- value
- 106
- title
- Prior Systemic Anticancer Regimens
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 10
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 27
- title
- Prior Stem Cell Transplants
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 15
- title
- Other Prior Anticancer Therapies
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Participants With Any Prior Cancer Treatment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1.815
- value
- 3.69
- group Id
- BG001
- spread
- 1.832
- value
- 3.25
- group Id
- BG002
- spread
- 1.946
- value
- 3.64
- group Id
- BG003
- spread
- 2.461
- value
- 3.64
- group Id
- BG004
- spread
- 1.309
- value
- 3.00
- group Id
- BG005
- spread
- 0.816
- value
- 3.00
- group Id
- BG006
- spread
- 0.519
- value
- 2.50
- group Id
- BG007
- spread
- 0.663
- value
- 2.14
- group Id
- BG008
- spread
- 0.579
- value
- 2.21
- group Id
- BG009
- spread
- 1.552
- value
- 2.99
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Number of Prior Systemic Anticancer Regimens Received
- unit Of Measure
- systemic anticancer regimens
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle